top of page

Interview | C-Suite Perspectives On AI: Leen Kawas Of Propel Bio Partners On Where to Use AI and Where to Rely Only on Humans

  • chance51029
  • Jan 2
  • 1 min read
Illustration of Leen Kawas presenting a comparison between AI and human capabilities on a board. She points to an icon of an ear in the “Human” column, surrounded by other symbols like a heart, handshake, and justice scales—contrasting with algorithm and data icons in the “AI” column. The scene emphasizes Kawas’s balanced approach to biotech, integrating empathy and ethics with innovation.

Leen Kawas shares the personal story that pushed her into biotech, from growing up in Amman to building and taking a company public, then shifting into venture as a co-founder of Propel Bio Partners. In this Q&A she talks candidly about early mistakes, what she is building now, and where she thinks AI actually helps life sciences versus where it falls short. She also lays out her framework for deciding when to use AI and when humans must stay in the lead, and ends with a bigger vision for “inclusive innovation by design” in global healthcare.



 
 
 

Comments

bottom of page